-
s Novel Arcyriaflavin-A Derivatives as PIM Kinase Inhibitors for Treating Cancer
- Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Volume 23, Issue 14, Aug 2023, p. 1697 - 1700
-
- 01 Aug 2023
Abstract
The present application reports a series of novel Arcyriaflavin-A derivatives as PIM kinase inhibitors for the effective treatment of cancer. The application also describes the synthesis of compounds in detail, use, pharmaceutical composition, pharmaceutically acceptable salts, and treatment.
© Bentham Science Publishers